Renal Nerve Stimulation Predicted Blood Pressure-Lowering Responses to Percutaneous Renal Denervation.
Hui-Chun Huang, Heng-Yu Pan, Tzung-Dau Wang
https://pubmed.ncbi.nlm.nih.gov/36802802/Actively Recruiting
Led by National Taiwan University Hospital · Updated on 2024-11-06
32
Participants Needed
1
Research Sites
86 weeks
Total Duration
This research aims to evaluate two methods of renal denervation in patients with hypertension, focusing on whether using intraprocedural feedback from renal artery stimulation can improve outcomes compared to the conventional approach. It builds on earlier findings that persistent blood pressure increases triggered by renal artery stimulation after the initial procedure indicate poorer blood pressure control six months later. The trial specifically compares a guided strategy that includes additional ablations based on immediate feedback to a standard approach without repeat procedures. Participants receive sedation with intravenous propofol during the procedure. Renal artery stimulation is performed at two sites in both renal arteries to measure systolic blood pressure response and artery constriction. Renal denervation is done with a multielectrode catheter applying radiofrequency ablations. After the initial denervation, stimulation is repeated to assess blood pressure changes. In the guided strategy group, further ablations target arteries where stimulation still causes a systolic blood pressure rise of 20 mmHg or more in the conventional group, no additional denervation is performed. During the study, participants are monitored for blood pressure changes over 24 hours at six months post-procedure, which is the main outcome. Secondary measures include changes in diastolic blood pressure, awake and asleep heart rate and blood pressure, and kidney function tests. Blood pressure readings are carefully averaged to reduce fluctuations, and body reactions during stimulation are recorded. The study runs from October 2024 to June 2028, with randomized assignment and triple masking to ensure objective results.
CONDITIONS
INtraprocedural Feedback-Optimized Renal Denervation Based on Measurements Obtained Through Renal Artery Stimulation: a Randomized Controlled Trial (INFORM)
T
Tzung-Dau Wang, MD, PhD
Y
Ya-Chun Chen, BS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Taiwan University Hospital
Lead Sponsor
Smart Health Technology Research and Development Center, National Taiwan University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - Day of the procedure
Participants undergo renal denervation using a multielectrode catheter with radiofrequency ablation guided by renal artery stimulation measurements.
1 in-person procedure visit
Duration - 6 months
Participants are monitored for blood pressure changes and kidney function for 6 months after the renal denervation procedure.
Periodic follow-up visits over 6 months
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Hui-Chun Huang, Heng-Yu Pan, Tzung-Dau Wang
https://pubmed.ncbi.nlm.nih.gov/36802802/National Taiwan University Hospital
Lead Sponsor
Smart Health Technology Research and Development Center, National Taiwan University
Collaborating Sponsor